Hepatoportal Sclerosis-A Clinicopathologic Review of 28 Cases

Overview

Journal Gastro Hep Adv

Specialty Gastroenterology

Date 2024 Aug 12

PMID 39132644

Authors

Nazia Khatoon

Andrew P Keaveny

Gian P Carames

Murli Krishna

Jason Lewis

Raouf E Nakhleh

Affiliations

Soon will be listed here.

Abstract

Background And Aims: The aim of this study was to review a large series of cases with hepatoportal sclerosis (HPS) as a pathologically recognizable entity in liver tissue specimens and describe the associated clinical and radiographic manifestations, along with the outcomes of this entity.

Methods: Data were collected through a retrospective chart review.

Results: Twenty-eight patients were identified that had pathologically defined HPS. All patients had a significant past medical history and signs and symptoms of portal hypertension. The most consistent laboratory finding was an elevated alkaline phosphatase. Radiographically, 9 patients were mistakenly identified as having advanced fibrosis/cirrhosis. The initial histologic diagnosis was made on biopsy in 20 patients and after transplant in 8 patients. The severity of symptoms was variable and required transplantation in 11 patients, 3 were treated with transjugular intrahepatic portosystemic shunt, and the remaining patients were treated symptomatically.

Conclusion: HPS is associated with past medical history that may be causal in nature. Signs and symptoms may be severe enough to require liver transplantation. A significant proportion of patients are radiographically misdiagnosed as cirrhosis. In this small series, overall outcomes for transplanted patients are acceptable.

References

Fan C, Crawford J . Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol. 2015; 4(4):332-46. PMC: 4298625. DOI: 10.1016/j.jceh.2014.10.002. View

Nakhleh R . The pathological differential diagnosis of portal hypertension. Clin Liver Dis (Hoboken). 2019; 10(3):57-62. PMC: 6467111. DOI: 10.1002/cld.655. View

Khanna R, Sarin S . Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol. 2013; 60(2):421-41. DOI: 10.1016/j.jhep.2013.08.013. View

Sarin S, Kumar A . Noncirrhotic portal hypertension. Clin Liver Dis. 2006; 10(3):627-51, x. DOI: 10.1016/j.cld.2006.08.021. View

Dhiman R, Chawla Y, Vasishta R, Kakkar N, Dilawari J, Trehan M . Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol. 2002; 17(1):6-16. DOI: 10.1046/j.1440-1746.2002.02596.x. View

Wanless I . Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology. 1990; 11(5):787-97. DOI: 10.1002/hep.1840110512. View

Schouten J, Verheij J, Seijo S . Idiopathic non-cirrhotic portal hypertension: a review. Orphanet J Rare Dis. 2015; 10:67. PMC: 4457997. DOI: 10.1186/s13023-015-0288-8. View

Krishnan P, Fiel M, Rosenkrantz A, Hajdu C, Schiano T, Oyfe I . Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation. AJR Am J Roentgenol. 2012; 198(2):370-6. DOI: 10.2214/AJR.11.6855. View

De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C . Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022; 76(4):959-974. PMC: 11090185. DOI: 10.1016/j.jhep.2021.12.022. View

10.

Jain P, Patel S, Simpson H, Silver R, Lewin D, Campbell R . Nodular Regenerative Hyperplasia of the Liver in Rheumatic Disease: Cases and Review of the Literature. J Investig Med High Impact Case Rep. 2021; 9:23247096211044617. PMC: 8436301. DOI: 10.1177/23247096211044617. View

11.

Sarin S, Philips C, Khanna R . Noncirrhotic portal hypertension: Medical and endoscopic management. Clin Liver Dis (Hoboken). 2019; 6(5):107-111. PMC: 6490692. DOI: 10.1002/cld.511. View

12.

Bodh V, Chawla Y . Noncirrhotic intrahepatic portal hypertension. Clin Liver Dis (Hoboken). 2019; 3(6):129-132. PMC: 6448719. DOI: 10.1002/cld.344. View